Clinical Trials
119 trialsNCT04488224 2026-05-19
Nano-X IG
University of Sydney
Phase EARLY_PHASE1 Withdrawn
NCT07052760 2026-04-29
Imaging of Solid Tumors Using DLL3 SPECT
University of California, San Francisco
Phase EARLY_PHASE1 Withdrawn
NCT06152523 2026-04-06
MONAMI
Assistance Publique - Hôpitaux de Paris
Phase 2 Withdrawn
NCT06922825 2026-01-21
Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT06967987 2026-01-21
BEMAFLOT
Institut Cancerologie de l'Ouest
Phase 2 Withdrawn
NCT07293520 2025-12-26
Improving Consent Experiences in Clinical Trials
Washington University School of Medicine
Phase NA Withdrawn
NCT04020029 2025-12-19
Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer
Stanford University
Phase NA Withdrawn
NCT04372641 2025-09-17
Testing the Safety of CB-5339 in Patients With Cancer
National Cancer Institute (NCI)
Phase 1 Withdrawn
NCT06762808 2025-08-15
Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT05000905 2025-08-06
Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training
University of California, San Francisco
Phase NA Withdrawn
NCT06161558 2025-07-16
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn
NCT05257707 2025-07-09
MOCA
Centre Hospitalier Universitaire de Besancon
Phase NA Withdrawn
NCT05222308 2025-07-08
Advanced Planning for Online Accounts and Data
University of Colorado, Denver
Phase NA Withdrawn
NCT06416436 2025-06-29
Dose-escalation Study of Ultra-high Dose Ablative Radiosurgery With Immunotherapy for Bulky Metastatic Cancer Patients
University of Kansas Medical Center
Phase 1 Withdrawn
NCT02591433 2025-05-01
JeffQuit Group Therapy Program for Smoking Cessation in Patients With a History of Cancer
Thomas Jefferson University
Phase NA Withdrawn
NCT06395090 2025-04-08
MK-9999-01B
Merck Sharp & Dohme LLC
Phase 1/2 Withdrawn
NCT05828303 2025-04-01
A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid Tumors
Turning Point Therapeutics, Inc.
Phase 1 Withdrawn
NCT06365918 2025-02-17
Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT04271436 2025-01-07
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Washington University School of Medicine
Phase 2 Withdrawn
NCT05653661 2025-01-07
Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors
Mayo Clinic
Phase 1 Withdrawn
NCT06654258 2024-11-26
Supporting Spiritual Wellbeing in Young Adults With Cancer Using a Digital Health Approach: A Feasibility Study
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT06023368 2024-11-14
Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray
University of Kentucky
Phase 4 Withdrawn
NCT05589857 2024-10-23
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT04135326 2024-10-09
Transcranial Direct Current Stimulation in Reducing Pain in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03003195 2024-09-03
The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients
University of Arkansas
Phase 2 Withdrawn
NCT05112458 2024-08-15
Cope 360 App for Caregivers of Children With Cancer
Indiana University
Phase NA Withdrawn
NCT04023240 2024-08-12
68-Ga-FAPI PET Imaging in Malignancy
Stanford University
Phase 2 Withdrawn
NCT05423808 2024-08-12
GerOnTe-TWOBE
Universitaire Ziekenhuizen KU Leuven
Phase NA Withdrawn
NCT05408195 2024-06-28
ONCO-CHATBOT
University Hospital, Toulouse
Phase NA Withdrawn
NCT03044795 2024-05-03
REPAIR
University Medical Center Groningen
Phase 2 Withdrawn
NCT05678283 2024-04-17
A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Withdrawn
NCT04294875 2024-03-06
MPT0B64
J Ints Bio
Phase EARLY_PHASE1 Withdrawn
NCT03668769 2024-02-23
Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking
M.D. Anderson Cancer Center
Phase NA Withdrawn
NCT05248425 2024-02-08
ME-Q
University Health Network, Toronto
Phase NA Withdrawn
NCT03671720 2024-02-07
Personalized Vaccine Generated by Autologous Dendritic Cells Pulsed With Autologous Whole Tumor Cell Lysate Treat Advanced Solid Tumor Patients With High Tumor Mutation Burden
Capital Medical University
Phase EARLY_PHASE1 Withdrawn
NCT05153447 2024-01-09
M-Tech
University of Rochester
Phase NA Withdrawn
NCT03341364 2023-10-24
Acceptance and Commitment Based Group Therapy for Cancer Patients
Region Skane
Phase NA Withdrawn
NCT05728372 2023-10-10
64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation
City of Hope Medical Center
Phase EARLY_PHASE1 Withdrawn
NCT01632436 2023-10-02
Hepatic
CTI BioPharma
Phase 1 Withdrawn
NCT05828277 2023-09-26
A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients
Turning Point Therapeutics, Inc.
Phase 1 Withdrawn
NCT05729139 2023-08-09
Cemiplimab/Peg-Interferon-α in Advanced CSCC
Baptist Health South Florida
Phase 1 Withdrawn
NCT04210726 2023-07-27
Effect of Salt Solution Immersion Bath on Cancer in Vivo.
Batroussy, Rafik
Phase NA Withdrawn
NCT05943301 2023-07-13
Study of the Impact of Non-pharmacological Techniques on Cognitive Complaints in Cancer Patients
University of Liege
Phase NA Withdrawn
NCT04114422 2023-07-03
A Seven-day Preoperative Exercise Training Program in People With Abdominal Cancer
Universidade Cidade de Sao Paulo
Phase NA Withdrawn
NCT03069287 2023-04-13
Integrating Family Caregiver Support Into Cancer Clinical Trials
Saint John's Cancer Institute
Phase NA Withdrawn
NCT05472220 2022-12-27
Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma
University of California, San Francisco
Phase 1 Withdrawn
NCT03906643 2022-12-20
HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies
Duke University
Phase 1 Withdrawn
NCT04528238 2022-10-27
Impact of Relaxing Visual Immersion on Anxiety During Anti-cancer Treatment.
Elsan
Phase NA Withdrawn
NCT04719416 2022-09-13
Relaxation Therapy in Pediatric Oncology
Geisinger Clinic
Phase NA Withdrawn
NCT04985825 2022-09-13
I-PACE
Centessa Pharmaceuticals plc
Phase 2 Withdrawn